Shortcomings in the current treatment of epilepsy

  title={Shortcomings in the current treatment of epilepsy},
  author={M. Eadie},
  journal={Expert Review of Neurotherapeutics},
  pages={1419 - 1427}
  • M. Eadie
  • Published 2012
  • Medicine
  • Expert Review of Neurotherapeutics
  • Contemporary drug therapy fails to control epileptic seizures in some 30% of patients, resulting in the need to employ other measures when they appear practicable. A good deal of potentially relevant statistical detail is available regarding the outcomes of the available antiepileptic therapies, but its interpretation is sometimes difficult because of uncertainty about the types of epilepsy to which it applies, and because of deficiencies in knowledge of the natural histories of the various… CONTINUE READING

    Topics from this paper.

    The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential
    • 14
    • PDF
    Optogenetic control of astrocytes: Is it possible to treat astrocyte-related epilepsy?
    • 22
    The dilemma of treatments for epileptic patients with depression
    • 5
    mTOR and MAPK: from localized translation control to epilepsy
    • 26